Breaking News Instant updates and real-time market news.

PTI

Proteostasis

$1.29 /

-0.045 (-3.38%)

07:03
08/24/20
08/24
07:03
08/24/20
07:03

Proteostasis, Yumanity Therapeutics announce merger agreement

Yumanity Therapeutics and Proteostasis Therapeutics announced that the companies have entered into a definitive merger agreement. The combined company, operating under the name Yumanity Therapeutics, will leverage a common scientific expertise in the area of protein misfolding to advance Yumanity's pipeline of innovative, disease-modifying programs for neurodegenerative diseases. Yumanity has raised more than $100M from leading investors that include Alexandria Venture Investments, Biogen, Fidelity, Merck, Pfizer, Redmile Group, and Sanofi Ventures. The company also recently entered into a strategic research collaboration with Merck for the discovery and development of novel agents for the treatment of ALS and FTLD with Yumanity eligible to receive future payments totaling approximately $500M in addition to royalties on the net sales of any marketed products. Upon the anticipated closing of the merger between PTI and Yumanity, Richard Peters, M.D., Ph.D., President, CEO and Director of Yumanity, will become President, CEO and Director of the combined company. Under the terms of the merger agreement, PTI will acquire all outstanding shares of Yumanity in exchange for newly-issued shares of PTI common stock. Upon completion of the proposed acquisition, it is anticipated that existing PTI shareholders will own approximately 32.5% of the combined company and Yumanity shareholders will own approximately 67.5% of the combined company. The actual allocation will be subject to adjustment based on each company's outstanding equity ownership and Proteostasis' net cash balance at the time of closing of the merger. Following completion of the merger, the Yumanity Board of Directors will be expanded to nine persons to include the appointment of two current Proteostasis directors. The existing Yumanity Directors will continue to serve in their current positions and Dr. Coles will remain as chairperson. The transaction has been approved by the boards of directors of both companies. The merger is expected to close in the fourth quarter of 2020, subject to customary closing conditions, including approval of the merger by the shareholders of PTI. The combined company is expected to trade on the NASDAQ Global Market under the ticker symbol YMTX. In conjunction with this merger announcement, PTI has reduced its workforce by 79%. As of today, PTI has five full time employees supporting the proposed merger transaction and strategic efforts related to PTI's CF assets.

PTI Proteostasis
$1.29 /

-0.045 (-3.38%)

02/24/20 Piper Sandler
Proteostasis' Phase III CHOICES trial fully enrolled, says Piper Sandler
12/23/19 H.C. Wainwright
Proteostasis data more positive than perceived, says H.C. Wainwright
12/17/19 Piper Sandler
Piper says 'positive' Proteostasis data de-risks Phase 3 TripleRx trials
12/17/19 RBC Capital
Proteostasis pullback a a buying opportunity, says RBC Capital

TODAY'S FREE FLY STORIES

Recommendations
CareDx entrenched deeper into transplants with Palmetto LCD, says Piper » 11:07
10/01/20
10/01
11:07
10/01/20
11:07
CDNA

CareDx

$41.38 /

+3.35 (+8.81%)

Palmetto issued a final…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDNA CareDx
$41.38 /

+3.35 (+8.81%)

CDNA CareDx
$41.38 /

+3.35 (+8.81%)

08:26 Today Craig-Hallum
CareDx may receive HeartCare Medicare reimbursement, says Craig-Hallum
08/06/20 BTIG
CareDx price target raised to $45 from $40 at BTIG
08/05/20 H.C. Wainwright
CareDx price target raised to $40 from $37 at H.C. Wainwright
06/29/20 Piper Sandler
CareDx a top pick in diagnostics at Piper Sandler
CDNA CareDx
$41.38 /

+3.35 (+8.81%)

  • 11
    Jun
Options
Rocket Companies call volume above normal and directionally bullish » 11:05
10/01/20
10/01
11:05
10/01/20
11:05
RKT

Rocket Companies

$21.24 /

+1.315 (+6.60%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

09/25/20 Susquehanna
Rocket Companies upgraded to Neutral on valuation at Susquehanna
09/25/20 Susquehanna
Rocket Companies upgraded to Neutral from Negative at Susquehanna
09/10/20 Wedbush
Rocket Companies initiated with a Neutral, $24 price target at Wedbush
09/09/20 Wedbush
Rocket Companies initiated with a Neutral at Wedbush
RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

  • 06
    Aug
RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

Periodicals
Celsius Holdings sinks following short report from 'The Bear Cave" » 11:02
10/01/20
10/01
11:02
10/01/20
11:02
CELH

Celsius Holdings

$23.91 /

+1.16 (+5.10%)

Shares of Celsius…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CELH Celsius Holdings
$23.91 /

+1.16 (+5.10%)

CELH Celsius Holdings
$23.91 /

+1.16 (+5.10%)

08/07/20 Ladenburg
Celsius Holdings price target raised to $23.50 from $11.75 at Ladenburg
08/06/20 Roth Capital
Celsius Holdings price target raised to $25 from $14.50 at Roth Capital
07/28/20 B. Riley FBR
Celsius Holdings price target raised to $17 from $11.50 at B. Riley FBR
06/24/20 Maxim
Celsius Holdings price target raised to $15 from $12 at Maxim
CELH Celsius Holdings
$23.91 /

+1.16 (+5.10%)

Recommendations
Solaria price target raised to EUR 18 from EUR 11 at RBC Capital » 11:02
10/01/20
10/01
11:02
10/01/20
11:02
SEYMF

Solaria

$0.00 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
The U.S. construction spending report beat estimates » 11:00
10/01/20
10/01
11:00
10/01/20
11:00

The U.S. construction…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Chardan boosts Solid Biosciences target 250% to $12.50 from $5 » 10:55
10/01/20
10/01
10:55
10/01/20
10:55
SLDB

Solid Biosciences

$4.42 /

+2.39 (+117.73%)

Chardan analyst Gbola…

Chardan analyst Gbola Amusa raised the firm's price target on Solid Biosciences to $12.50 from $5 and keeps a Buy rating on the shares after the FDA lifted the clinical hold on the Phase I/II IGNITE DMD trial of AAV9-based gene therapy SGT-001 in Duchenne muscular dystrophy. Today's news is an "important positive" given that manufacturing constraints in the space leave an opportunity for Solid, and the view from many in the market that SGT-001 may not return to the clinic, Amusa tells investors in a research note. Duchenne muscular dystrophy is a "vast opportunity" for gene therapies, and one that could take Solid "significantly past" the new price target with progress, adds the analyst. The stock in morning trading is up 125% to $4.56.

ShowHide Related Items >><<
SLDB Solid Biosciences
$4.42 /

+2.39 (+117.73%)

SLDB Solid Biosciences
$4.42 /

+2.39 (+117.73%)

10:47 Today Chardan
Solid Biosciences price target raised to $12.50 from $5 at Chardan
07/28/20 SVB Leerink
Solid Biosciences downgraded to Market Perform at SVB Leerink
07/28/20 SVB Leerink
Solid Biosciences downgraded to Market Perform from Outperform at SVB Leerink
05/08/20 Nomura Instinet
Solid Biosciences price target lowered to $6 from $10 at Nomura Instinet
Options
AbbVie put volume heavy and directionally bearish » 10:55
10/01/20
10/01
10:55
10/01/20
10:55
ABBV

AbbVie

$87.65 /

+0.13 (+0.15%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

09/29/20 Berenberg
AbbVie initiated with a Hold at Berenberg
09/28/20 Mizuho
Mizuho 'incrementally more bullish' on AbbVie integration of Allergan
09/02/20 Citi
AbbVie revenue potential offsets subpoena risk, says Citi
08/24/20 H.C. Wainwright
Galapagos downgraded to Neutral from Buy at H.C. Wainwright
ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

Conference/Events
Federal Reserve Bank of New York to hold a virtual conference » 10:55
10/01/20
10/01
10:55
10/01/20
10:55
UBS

UBS

$11.17 /

+0.005 (+0.04%)

, GS

Goldman Sachs

$200.10 /

-1.01 (-0.50%)

2nd New York Fed Research…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBS UBS
$11.17 /

+0.005 (+0.04%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

UBS UBS
$11.17 /

+0.005 (+0.04%)

07/24/20 Morgan Stanley
UBS price target raised to CHF 12 from CHF 11 at Morgan Stanley
07/23/20 Oddo BHF
UBS upgraded to Neutral from Reduce at Oddo BHF
07/22/20 Credit Suisse
UBS price target raised to CHF 14.50 from CHF 14 at Credit Suisse
07/22/20 RBC Capital
UBS price target raised to CHF 12 from CHF 11 at RBC Capital
GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

09/30/20 BofA
Goldman Sachs added to US 1 List, Citi removed at BofA
09/23/20 UBS
Goldman Sachs upgraded to Buy from Neutral at UBS
08/06/20 Piper Sandler
Now is the time to buy Goldman Sachs, says Piper Sandler
07/20/20 Berenberg
Goldman Sachs price target raised to $200 from $160 at Berenberg
UBS UBS
$11.17 /

+0.005 (+0.04%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

UBS UBS
$11.17 /

+0.005 (+0.04%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

UBS UBS
$11.17 /

+0.005 (+0.04%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

Conference/Events
Federal Reserve Bank of New York participates in a virtual conference » 10:55
10/01/20
10/01
10:55
10/01/20
10:55

New York Federal Reserve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
BRP Group Inc (Class A Stock) trading resumes  10:54
10/01/20
10/01
10:54
10/01/20
10:54
BRP

BRP Group

$25.23 /

+0.32 (+1.28%)

 
ShowHide Related Items >><<
BRP BRP Group
$25.23 /

+0.32 (+1.28%)

BRP BRP Group
$25.23 /

+0.32 (+1.28%)

08/24/20 Canaccord
BRP Group price target raised to C$70 from C$60 at Canaccord
08/24/20 Raymond James
BRP Group price target raised to $25 from $18 at Raymond James
08/17/20 Jefferies
BRP Group price target raised to $21 from $12 at Jefferies
08/14/20 Keefe Bruyette
BRP Group price target raised to $24 from $19 at Keefe Bruyette
BRP BRP Group
$25.23 /

+0.32 (+1.28%)

  • 25
    Jun
  • 24
    Oct
BRP BRP Group
$25.23 /

+0.32 (+1.28%)

Recommendations
Chemtrade Logistics price target lowered to C$5.50 from C$6.50 at TD Securities » 10:53
10/01/20
10/01
10:53
10/01/20
10:53
CGIFF

Chemtrade Logistics

$0.00 /

+ (+0.00%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGIFF Chemtrade Logistics
$0.00 /

+ (+0.00%)

08/27/20 TD Securities
Chemtrade Logistics financing reduces near-term risk, says TD Securities
08/27/20 BMO Capital
Chemtrade Logistics price target lowered to C$7.50 from C$7.75 at BMO Capital
08/17/20 CIBC
Chemtrade Logistics price target raised to C$7.50 from C$7 at CIBC
08/17/20 RBC Capital
Chemtrade Logistics price target raised to C$7 from C$6 at RBC Capital
Recommendations
MTY Food Group price target raised to C$32 from C$28 at TD Securities » 10:52
10/01/20
10/01
10:52
10/01/20
10:52
MTYFF

MTY Food Group

$0.00 /

+ (+0.00%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTYFF MTY Food Group
$0.00 /

+ (+0.00%)

09/23/20 National Bank
MTY Food Group price target raised to C$35 from C$32 at National Bank
07/13/20 Scotiabank
Scotiabank backs Sector Perform on MTY Food Group after 'solid' quarter
07/13/20 RBC Capital
MTY Food Group price target raised to C$27 from C$22 at RBC Capital
07/13/20 National Bank
MTY Food Group price target raised to C$32 from C$29 at National Bank
Recommendations
Suncor price target lowered to C$28 from C$30 at BMO Capital » 10:51
10/01/20
10/01
10:51
10/01/20
10:51
SU

Suncor

$11.85 /

-0.38 (-3.11%)

BMO Capital analyst Randy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SU Suncor
$11.85 /

-0.38 (-3.11%)

SU Suncor
$11.85 /

-0.38 (-3.11%)

09/30/20 Scotiabank
Suncor price target lowered to C$27 from C$30 at Scotiabank
09/18/20 TD Securities
Suncor price target lowered to C$31 from C$32 at TD Securities
09/09/20 RBC Capital
Suncor price target lowered to C$25 from C$28 at RBC Capital
09/09/20 TD Securities
Suncor price target lowered to C$32 from C$34 at TD Securities
SU Suncor
$11.85 /

-0.38 (-3.11%)

SU Suncor
$11.85 /

-0.38 (-3.11%)

Hot Stocks
Amag announces agreement to be acquired by Covis for $13.75 per share in cash » 10:50
10/01/20
10/01
10:50
10/01/20
10:50
AMAG

Amag Pharmaceuticals

$12.83 /

+3.41 (+36.20%)

Covis Group S.a r.l. and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMAG Amag Pharmaceuticals
$12.83 /

+3.41 (+36.20%)

AMAG Amag Pharmaceuticals
$12.83 /

+3.41 (+36.20%)

08/19/20 Truist
Amag Pharmaceuticals price target raised to $10 from $7 at Truist
08/18/20
Fly Intel: Top five analyst downgrades
08/18/20 Barclays
Barclays downgrades Amag Pharmaceuticals after 130% rally from lows
08/18/20 Barclays
Amag Pharmaceuticals downgraded to Equal Weight from Overweight at Barclays
AMAG Amag Pharmaceuticals
$12.83 /

+3.41 (+36.20%)

AMAG Amag Pharmaceuticals
$12.83 /

+3.41 (+36.20%)

General news
FX Action: USD-CAD » 10:50
10/01/20
10/01
10:50
10/01/20
10:50

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Ring Energy to host conference call » 10:50
10/01/20
10/01
10:50
10/01/20
10:50
REI

Ring Energy

$0.70 /

+0.0173 (+2.53%)

Management discusses the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REI Ring Energy
$0.70 /

+0.0173 (+2.53%)

REI Ring Energy
$0.70 /

+0.0173 (+2.53%)

09/16/20 Alliance Global Partners
Ring Energy assumed with a Neutral at Alliance Global Partners
08/11/20 Alliance Global Partners
Ring Energy asset sale overhang remains, says Alliance Global Partners
03/17/20 Alliance Global Partners
Ring Energy downgraded to Neutral from Buy at Alliance Global Partners
03/17/20 Johnson Rice
Ring Energy downgraded to Accumulate from Buy at Johnson Rice
REI Ring Energy
$0.70 /

+0.0173 (+2.53%)

Hot Stocks
BRP Group Inc (Class A Stock) trading halted, volatility trading pause  10:49
10/01/20
10/01
10:49
10/01/20
10:49
BRP

BRP Group

$24.93 /

+0.015 (+0.06%)

 
ShowHide Related Items >><<
BRP BRP Group
$24.93 /

+0.015 (+0.06%)

BRP BRP Group
$24.93 /

+0.015 (+0.06%)

08/24/20 Canaccord
BRP Group price target raised to C$70 from C$60 at Canaccord
08/24/20 Raymond James
BRP Group price target raised to $25 from $18 at Raymond James
08/17/20 Jefferies
BRP Group price target raised to $21 from $12 at Jefferies
08/14/20 Keefe Bruyette
BRP Group price target raised to $24 from $19 at Keefe Bruyette
BRP BRP Group
$24.93 /

+0.015 (+0.06%)

  • 25
    Jun
  • 24
    Oct
BRP BRP Group
$24.93 /

+0.015 (+0.06%)

Hot Stocks
Amag announces agreement to be acquired by Covis for $13.75 per share in cash  10:49
10/01/20
10/01
10:49
10/01/20
10:49
AMAG

Amag Pharmaceuticals

$12.85 /

+3.43 (+36.41%)

 
ShowHide Related Items >><<
AMAG Amag Pharmaceuticals
$12.85 /

+3.43 (+36.41%)

AMAG Amag Pharmaceuticals
$12.85 /

+3.43 (+36.41%)

08/19/20 Truist
Amag Pharmaceuticals price target raised to $10 from $7 at Truist
08/18/20
Fly Intel: Top five analyst downgrades
08/18/20 Barclays
Barclays downgrades Amag Pharmaceuticals after 130% rally from lows
08/18/20 Barclays
Amag Pharmaceuticals downgraded to Equal Weight from Overweight at Barclays
AMAG Amag Pharmaceuticals
$12.85 /

+3.43 (+36.41%)

AMAG Amag Pharmaceuticals
$12.85 /

+3.43 (+36.41%)

Recommendations
Sumo Group price target raised to 260 GBp from 230 GBp at Canaccord » 10:49
10/01/20
10/01
10:49
10/01/20
10:49
SUMGF

Sumo Group

$0.00 /

+ (+0.00%)

Canaccord analyst Steve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Ferguson price target raised to 8,000 GBp from 7,460 GBp at Canaccord » 10:47
10/01/20
10/01
10:47
10/01/20
10:47
FERGY

Ferguson

/

+

Canaccord analyst Aynsley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FERGY Ferguson
/

+

09/30/20 Barclays
Ferguson price target raised to 8,000 GBp from 6,900 GBp at Barclays
09/30/20 JPMorgan
Ferguson price target raised to 8,200 GBp from 7,900 GBp at JPMorgan
09/30/20 RBC Capital
Ferguson upgraded to Sector Perform from Underperform at RBC Capital
09/24/20 Canaccord
Ferguson price target raised to 7,460 GBp from 6,945 GBp at Canaccord
Recommendations
Solid Biosciences price target raised to $12.50 from $5 at Chardan » 10:47
10/01/20
10/01
10:47
10/01/20
10:47
SLDB

Solid Biosciences

$4.70 /

+2.67 (+131.53%)

Chardan analyst Gbola…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLDB Solid Biosciences
$4.70 /

+2.67 (+131.53%)

SLDB Solid Biosciences
$4.70 /

+2.67 (+131.53%)

07/28/20 SVB Leerink
Solid Biosciences downgraded to Market Perform at SVB Leerink
07/28/20 SVB Leerink
Solid Biosciences downgraded to Market Perform from Outperform at SVB Leerink
05/08/20 Nomura Instinet
Solid Biosciences price target lowered to $6 from $10 at Nomura Instinet
05/07/20 Evercore ISI
Solid Biosciences downgraded to In Line from Outperform at Evercore ISI
General news
The U.S. ISM drop to a still-firm 55.4 » 10:45
10/01/20
10/01
10:45
10/01/20
10:45

The U.S. ISM drop to a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
New York Federal Reserve Bank President John Williams Speech to be released at 11:00  10:45
10/01/20
10/01
10:45
10/01/20
10:45
 
General news
New York Federal Reserve Bank President John Williams Speech to be released at 11:00  10:45
10/01/20
10/01
10:45
10/01/20
10:45
 
General news
3-Month Bill Announcement to be released at 11:00  10:45
10/01/20
10/01
10:45
10/01/20
10:45
 

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.